These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 10982200)
1. An open-label trial of St. John's Wort (Hypericum perforatum) in obsessive-compulsive disorder. Taylor LH; Kobak KA J Clin Psychiatry; 2000 Aug; 61(8):575-8. PubMed ID: 10982200 [TBL] [Abstract][Full Text] [Related]
2. St John's wort versus placebo in obsessive-compulsive disorder: results from a double-blind study. Kobak KA; Taylor LV; Bystritsky A; Kohlenberg CJ; Greist JH; Tucker P; Warner G; Futterer R; Vapnik T Int Clin Psychopharmacol; 2005 Nov; 20(6):299-304. PubMed ID: 16192837 [TBL] [Abstract][Full Text] [Related]
3. Effectiveness of St John's wort in major depression: a randomized controlled trial. Shelton RC; Keller MB; Gelenberg A; Dunner DL; Hirschfeld R; Thase ME; Russell J; Lydiard RB; Crits-Cristoph P; Gallop R; Todd L; Hellerstein D; Goodnick P; Keitner G; Stahl SM; Halbreich U JAMA; 2001 Apr; 285(15):1978-86. PubMed ID: 11308434 [TBL] [Abstract][Full Text] [Related]
4. Comparison of St John's wort and imipramine for treating depression: randomised controlled trial. Woelk H BMJ; 2000 Sep; 321(7260):536-9. PubMed ID: 10968813 [TBL] [Abstract][Full Text] [Related]
5. An open-label pilot study of St. John's wort in juvenile depression. Findling RL; McNamara NK; O'Riordan MA; Reed MD; Demeter CA; Branicky LA; Blumer JL J Am Acad Child Adolesc Psychiatry; 2003 Aug; 42(8):908-14. PubMed ID: 12874492 [TBL] [Abstract][Full Text] [Related]
6. St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties. Barnes J; Anderson LA; Phillipson JD J Pharm Pharmacol; 2001 May; 53(5):583-600. PubMed ID: 11370698 [TBL] [Abstract][Full Text] [Related]
8. Superior efficacy of St John's wort extract WS 5570 compared to placebo in patients with major depression: a randomized, double-blind, placebo-controlled, multi-center trial [ISRCTN77277298]. Kasper S; Anghelescu IG; Szegedi A; Dienel A; Kieser M BMC Med; 2006 Jun; 4():14. PubMed ID: 16796730 [TBL] [Abstract][Full Text] [Related]
9. The efficacy of Hypericum perforatum (St John's wort) for the treatment of premenstrual syndrome: a randomized, double-blind, placebo-controlled trial. Canning S; Waterman M; Orsi N; Ayres J; Simpson N; Dye L CNS Drugs; 2010 Mar; 24(3):207-25. PubMed ID: 20155996 [TBL] [Abstract][Full Text] [Related]
10. St John's wort for depression. Linde K; Mulrow CD Cochrane Database Syst Rev; 2000; (2):CD000448. PubMed ID: 10796719 [TBL] [Abstract][Full Text] [Related]
11. Hypericum perforatum (St John's wort) for attention-deficit/hyperactivity disorder in children and adolescents: a randomized controlled trial. Weber W; Vander Stoep A; McCarty RL; Weiss NS; Biederman J; McClellan J JAMA; 2008 Jun; 299(22):2633-41. PubMed ID: 18544723 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial. Lecrubier Y; Clerc G; Didi R; Kieser M Am J Psychiatry; 2002 Aug; 159(8):1361-6. PubMed ID: 12153829 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of hypericum extract WS 5572 versus placebo in mildly to moderately depressed patients. A randomized double-blind multicenter clinical trial. Kalb R; Trautmann-Sponsel RD; Kieser M Pharmacopsychiatry; 2001 May; 34(3):96-103. PubMed ID: 11434406 [TBL] [Abstract][Full Text] [Related]
14. Effects of Hypericum perforatum (St. John's wort) on hot flashes and quality of life in perimenopausal women: a randomized pilot trial. Al-Akoum M; Maunsell E; Verreault R; Provencher L; Otis H; Dodin S Menopause; 2009; 16(2):307-14. PubMed ID: 19194342 [TBL] [Abstract][Full Text] [Related]
15. Olanzapine augmentation of fluvoxamine-refractory obsessive-compulsive disorder (OCD): a 12-week open trial. Bogetto F; Bellino S; Vaschetto P; Ziero S Psychiatry Res; 2000 Oct; 96(2):91-8. PubMed ID: 11063782 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum). Johne A; Brockmöller J; Bauer S; Maurer A; Langheinrich M; Roots I Clin Pharmacol Ther; 1999 Oct; 66(4):338-45. PubMed ID: 10546917 [TBL] [Abstract][Full Text] [Related]
17. Defining clinical severity in adults with obsessive-compulsive disorder. Storch EA; De Nadai AS; Conceição do Rosário M; Shavitt RG; Torres AR; Ferrão YA; Miguel EC; Lewin AB; Fontenelle LF Compr Psychiatry; 2015 Nov; 63():30-5. PubMed ID: 26555489 [TBL] [Abstract][Full Text] [Related]
18. Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder. Chouinard G; Goodman W; Greist J; Jenike M; Rasmussen S; White K; Hackett E; Gaffney M; Bick PA Psychopharmacol Bull; 1990; 26(3):279-84. PubMed ID: 2274626 [TBL] [Abstract][Full Text] [Related]
19. [Mania during the use of a combination preparation with St. John's wort (Hypericum perforatum)]. Güzelcan Y; Scholte WF; Assies J; Becker HE Ned Tijdschr Geneeskd; 2001 Oct; 145(40):1943-5. PubMed ID: 11675976 [TBL] [Abstract][Full Text] [Related]
20. How effective is St John's wort? The evidence revisited. Werneke U; Horn O; Taylor DM J Clin Psychiatry; 2004 May; 65(5):611-7. PubMed ID: 15163246 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]